- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/86 - Oxygen atoms
Patent holdings for IPC class C07D 211/86
Total number of patents in this class: 150
10-year publication summary
|
15
|
24
|
11
|
6
|
8
|
12
|
4
|
7
|
4
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
11 |
| Shionogi & Co., Ltd. | 883 |
8 |
| Mitsui Chemicals Agro, Inc. | 79 |
6 |
| ViiV Healthcare Company | 164 |
6 |
| Epizyme, Inc. | 360 |
5 |
| F. Hoffmann-La Roche AG | 7808 |
4 |
| Genentech, Inc. | 4114 |
4 |
| Nitto Denko Corporation | 8558 |
4 |
| Arcus Biosciences, Inc. | 166 |
4 |
| Unichem Laboratories Limited | 91 |
4 |
| Oxular Acquisitions Limited | 21 |
4 |
| Janssen Pharmaceuticals, Inc. | 433 |
3 |
| Syngenta Participations AG | 1495 |
3 |
| C4 Theraprutics, Inc. | 64 |
3 |
| Huscion Co., Ltd. | 10 |
3 |
| Glaxosmithkline LLC | 526 |
2 |
| The Regents of the University of California | 20815 |
2 |
| AstraZeneca AB | 2824 |
2 |
| Pfizer Inc. | 3409 |
2 |
| Massachusetts Institute of Technology | 10282 |
2 |
| Other owners | 68 |